State-of-the-Art DEA-Registered Research Facility in South Plainfield, NJ
Our chemists are trained and equipped to meet the specialized shipping & receiving, record-keeping and secure-storage processes required to maintain full compliance through all activities, from Synthesis, Analysis and Crystallization to cGMP.
J-STAR’s South Plainfield facility is registered with the DEA as a research facility for the following schedules:
DEA Schedule II-V
- Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence, e.g., cocaine, methamphetamine, methadone, hydromorphone, meperidine, oxycodone fentanyl, etc.
- Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence, e.g., products containing less than 90 milligrams of codeine per dosage unit.
- Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence, e.g., many sleep aids and anti-anxiety medications.
- Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes.